American Vietnamese Biotech (HSTC:AMV) LT-Debt-to-Total-Asset: 0.00 (As of . 20)


What is American Vietnamese Biotech LT-Debt-to-Total-Asset?

American Vietnamese Biotech HSTC:AMV LT-Debt-to-Total-Asset is 0.00 as of . 20.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. American Vietnamese Biotech's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

American Vietnamese Biotech's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).

American Vietnamese Biotech  (HSTC:AMV) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

American Vietnamese Biotech LT-Debt-to-Total-Asset Related Terms

American Vietnamese Biotech LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech LT-Debt-to-Total-Asset Chart

American Vietnamese Biotech Annual Data
Trend
LT-Debt-to-Total-Asset

American Vietnamese Biotech Quarterly Data
LT-Debt-to-Total-Asset

American Vietnamese Biotech LT-Debt-to-Total-Asset Calculation

American Vietnamese Biotech's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

American Vietnamese Biotech's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
American Vietnamese Biotech (HSTC:AMV) has a LT-Debt-to-Total-Asset of 0.00 as of . 20. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's LT-Debt-to-Total-Asset too high?
American Vietnamese Biotech's current LT-Debt-to-Total-Asset is 0.00.
How does American Vietnamese Biotech's LT-Debt-to-Total-Asset compare to HSTC and STLT?
American Vietnamese Biotech's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current LT-Debt-to-Total-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.